SFM
PMN icon

Sphera Funds Management’s ProMIS Neurosciences PMN Stock Holding History

Sphera Funds Management’s Portfolio PMN Stock Details PMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.14M Buy
325,591
+313,784
+2,658% +$4.68M 0.66% 55
2025
Q4 		$80.6K Hold
11,807
– – 0.02% 98
2025
Q3 		$125K Sell
11,807
-64,165
-84% -$888K 0.03% 112
2025
Q2 		$919K Sell
75,972
-1,200
-2% -$16.4K 0.22% 90
2025
Q1 		$1.34M Hold
77,172
– – 0.31% 81
2024
Q4 		$1.83M Hold
77,172
– – 0.33% 82
2024
Q3 		$2.41M Buy
77,172
+4,603
+6% +$172K 0.38% 74
2024
Q2 		$2.72M Sell
72,569
-793
-1% -$37.1K 0.37% 75
2024
Q1 		$3.5M Hold
73,362
– – 0.49% 60
2023
Q4 		$2.11M Hold
73,362
– – 0.34% 71
2023
Q3 		$3.69M Buy
+73,362
New +$4.77M 0.67% 50

Other funds holding PMN

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $273M AUM
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Sphera Funds Management's PMN Position: Q1 2026 in Review

Sphera Funds Management increased its ProMIS Neurosciences (PMN) stake by 2,658% in Q1 2026, buying an estimated $4.68M and bringing the position to 325,591 shares worth $4.14M. The position accounts for 0.66% of the portfolio, ranked #55.

Sphera Funds Management first reported a position in PMN in Q3 2023 and has held it in 11 quarters since. 25 funds tracked by Wall St. Rank hold PMN as of Q1 2026.

  • Sphera Funds Management held 325,591 shares of ProMIS Neurosciences worth $4.14M as of Q1 2026.
  • Sphera Funds Management bought 313,784 ProMIS Neurosciences shares in Q1 2026, an estimated $4.68M.
  • ProMIS Neurosciences made up 0.66% of Sphera Funds Management's portfolio in Q1 2026, its #55 holding.
  • Sphera Funds Management first reported a position in ProMIS Neurosciences in Q3 2023 and has held it in 11 quarters since.
  • 25 funds tracked by Wall St. Rank held ProMIS Neurosciences as of Q1 2026.

Based on Sphera Funds Management's 13F filing for Q1 2026, filed 15 May 2026.